Study on the damage of liver in patients with SARS

OBJECTIVE: To study the changes in liver function and histopathology, and investigate the underlying mechanism and clinical significance of damage of liver in patients with severe acute respiratory syndrome (SARS)

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 16(2004), 5 vom: 06. Mai, Seite 267-70
1. Verfasser: Guan, Yu-juan (VerfasserIn)
Weitere Verfasser: Tang, Xiao-ping, Yin, Chi-biao, Yi, Zheng-qing
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2004
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:Comparative Study English Abstract Journal Article Research Support, Non-U.S. Gov't Albumins L-Lactate Dehydrogenase EC 1.1.1.27 Aspartate Aminotransferases EC 2.6.1.1 Alanine Transaminase mehr... EC 2.6.1.2 Alkaline Phosphatase EC 3.1.3.1 Bilirubin RFM9X3LJ49
LEADER 01000caa a22002652 4500
001 NLM148234623
003 DE-627
005 20250205131738.0
007 tu
008 231223s2004 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0494.xml 
035 |a (DE-627)NLM148234623 
035 |a (NLM)15132787 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Guan, Yu-juan  |e verfasserin  |4 aut 
245 1 0 |a Study on the damage of liver in patients with SARS 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 10.11.2004 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To study the changes in liver function and histopathology, and investigate the underlying mechanism and clinical significance of damage of liver in patients with severe acute respiratory syndrome (SARS) 
520 |a METHODS: According the clinical diagnostic standard of atypical pneumonia of Ministry of Health P. R. China, liver function was assessed in 110 SARS patients admitted from February 2003 to June 2003. Of them 8 SARS patients died, and the livers were pathologically examined, and their liver function parameters were compared with that of the 35 healthy controls 
520 |a RESULTS: Alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), total bilirubin (TBil) of patients with SARS were higher than those of controls, they were (91.61+/-50.53) U/L vs. (32.91+/-10.56) U/L, (78.68+/-33.32) U/L vs. (29.43+/-8.89) U/L, (429.95+/-188.94) U/L vs. (200.83+/-44.86) U/L, (11.67+/-4.26) micromol/L vs. (8.44+/-3.86) micromol/L, all P<0.001. Albumin (ALB) and pro-albumin (PAB) of patients with SARS were lower than those of controls, they were (34.40+/-5.13) g/L vs. (42.09+/-6.79) g/L, (0.20+/-0.06) g/L vs. (0.34+/-0.05) g/L, both P<0.001. Direct reaction bilirubin (DBil), total bile acid (TBA), gamma-glutamyltransferase (GGT) and alkaline phosphatase (ALP) showed no marked difference between SARS patients and controls, all P>0.05. Non-specific inflammation in the liver was observed in pathological examination in 4 cases. ALT, AST, GGT and LDH were always 4 to 9 times of normal. The ratio of abnormality of ALT, AST and PAB were more than 80.0 percent, the ratio of abnormality of ALB was 42.7 percent, and less than 30.0 percent for other indexes. The average of LDH, ALT, and AST of dead patients were higher than those of the survivors. Histopathology of liver was non-specific hepatitis 
520 |a CONCLUSION: The patients with SARS are prone to have mild non-specific hepatitis. It seldom causes the typical symptoms of hepatitis and it is easy to be ignored in clinic 
650 4 |a Comparative Study 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Albumins  |2 NLM 
650 7 |a L-Lactate Dehydrogenase  |2 NLM 
650 7 |a EC 1.1.1.27  |2 NLM 
650 7 |a Aspartate Aminotransferases  |2 NLM 
650 7 |a EC 2.6.1.1  |2 NLM 
650 7 |a Alanine Transaminase  |2 NLM 
650 7 |a EC 2.6.1.2  |2 NLM 
650 7 |a Alkaline Phosphatase  |2 NLM 
650 7 |a EC 3.1.3.1  |2 NLM 
650 7 |a Bilirubin  |2 NLM 
650 7 |a RFM9X3LJ49  |2 NLM 
700 1 |a Tang, Xiao-ping  |e verfasserin  |4 aut 
700 1 |a Yin, Chi-biao  |e verfasserin  |4 aut 
700 1 |a Yi, Zheng-qing  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 16(2004), 5 vom: 06. Mai, Seite 267-70  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:16  |g year:2004  |g number:5  |g day:06  |g month:05  |g pages:267-70 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 16  |j 2004  |e 5  |b 06  |c 05  |h 267-70